Onconova Therapeutics
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Option
ALTLAND JAMES officer: SVP, Finance & Corp. D..
 Common Stock 5,000 N/A N/A
Option
ALTLAND JAMES officer: SVP, Finance & Corp. D..
 Stock Option (right to purchase) 5,000 N/A N/A
Option
ALTLAND JAMES officer: SVP, Finance & Corp. D..
 Common Stock 5,000 N/A N/A
Purchase
MCKEARN THOMAS J officer: President, R&D
 Common Stock 3,333 N/A N/A
Purchase
KUMAR RAMESH director, officer: Chief Execut..
 Common Stock 6,667 N/A N/A
Purchase
MEHTA VIREN director
 Common Stock 16,667 N/A N/A
Purchase
HOFFMAN MICHAEL B director
 Common Stock 1,000,000 N/A N/A
Purchase
BIENEN HENRY S director
 Common Stock 6,667 N/A N/A
Purchase
REDDY E PREMKUMAR director
 Common Stock 20,000 N/A N/A
Purchase
MICHAEL & JANE HOFFMAN 2013 DESCENDANTS 10 percent owner
 Common Stock 1,000,000 N/A N/A
Purchase
BAXTER HEALTHCARE SA 10 percent owner
 Common Stock 330,000 N/A N/A
Purchase
REDDY E PREMKUMAR director
 Common Stock 1,000 N/A N/A
Sale
KUMAR RAMESH director, officer: Chief Execut..
 Common Stock 13,543 N/A N/A

Showing 150 to 163 of 163 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.

Similar companies insider trading: